Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels
Maria do Carmo Costa(Michigan United), Patrı́cia Maciel(University of Minho)
Cited by 29
Related Papers
From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
|Neurotherapeutics|2019|73
Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado–Joseph disease
|Neuroscience|2015|30
Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3
|Frontiers in Molecular Neuroscience|2023|9
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein
|bioRxiv (Cold Spring Harbor Laboratory)|2019|2
Regional and age-dependent changes in ubiquitination in cellular and mouse models of Spinocerebellar ataxia type 3
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0